Can-fite Biopharma Stock Forecast

Sell candidate since Jun 18, 2026 Gain 2.68%

The Can-Fite BioPharma Ltd stock price gained 2.68% on the last trading day (Monday, 22nd Jun 2026), rising from $2.98 to $3.06. During the last trading day the stock fluctuated 6.53% from a day low at $2.91 to a day high of $3.10. The price has been going up and down for this period, and there has been a -0.97% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 91 thousand more shares were traded than the day before. In total, 99 thousand shares were bought and sold for approximately $304.02 thousand.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Can-Fite BioPharma Ltd stock with a 90% probability to be traded between $2.87 and $3.71 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

CANF Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 8.51%. Further rise is indicated until a new top pivot has been found. Can-Fite BioPharma Ltd has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Can-Fite BioPharma Ltd stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $3.23. On a fall, the stock will find some support from the short-term average at $2.96. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Can-Fite BioPharma Ltd stock

Can-Fite BioPharma Ltd finds support from accumulated volume at $3.03 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.190 between high and low, or 6.53%. For the last week, the stock has had daily average volatility of 5.37%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CANF) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Can-Fite BioPharma Ltd to open at $3.02, and during the day (based on 14 day Average True Range), to move between $2.97 and $3.15, which gives a possible trading interval of +/-$0.175 (+/-5.89%) up or down from last closing price. If Can-Fite BioPharma Ltd takes out the full calculated possible swing range there will be an estimated 5.89% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.03 (0.98%) than the resistance at $3.19 (4.25%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Can-Fite BioPharma Ltd stock A Buy?

Can-Fite BioPharma Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.675 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $3.02 ( 1.20%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk